National Research CorpNRC
NRC
About: National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
Employees: 368
0
Funds holding %
of 7,296 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0.47% less ownership
Funds ownership: 50.59% [Q4 2024] → 50.12% (-0.47%) [Q1 2025]
8% less funds holding
Funds holding: 133 [Q4 2024] → 123 (-10) [Q1 2025]
30% less capital invested
Capital invested by funds: $210M [Q4 2024] → $147M (-$62.3M) [Q1 2025]
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
33% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 52
Research analyst outlook
We haven’t received any recent analyst ratings for NRC.
Financial journalist opinion
Positive
Zacks Investment Research
1 month ago
NRC Q1 Earnings Dip Y/Y Amid Rising Interest Costs, Shares Up 13%
National Research reports a year-over-year decline in Q1 earnings, pressured by rising interest costs, declining revenues, and higher debt levels amid ongoing sales force expansion.
Neutral
Business Wire
1 month ago
NRC Health Announces First Quarter Results
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the first quarter 2025 and other corporate developments. Highlights: Total Recurring Value Contract Value Increases Sequentially Sales Force Expansion Accelerates New Share Repurchase Program Announced Operating Expenses Decline Dividend Declared Overview Michael D. Hays, Chief Executive Officer of NRC Health, commented on the Company's performance and recent developments: “Th.
Neutral
Business Wire
2 months ago
National Research Corporation Declares Quarterly Dividend
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ: NRC) announced that its Board of Directors has declared a quarterly cash dividend of $0.12 (twelve cents) per share payable Friday, April 11, 2025, to shareholders of record as of the close of business on Friday, March 28, 2025. For more than 40 years, NRC Health (NASDAQ: NRC) has led the charge to humanize healthcare and support organizations in their understanding of each unique individual. NRC Health's co.
Neutral
Business Wire
3 months ago
National Research Corporation Appoints Trent Green as Chief Executive Officer
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation (NASDAQ: NRC), doing business as NRC Health, a publicly-traded leader in healthcare improvement, is pleased to announce the appointment of Trent Green as its incoming Chief Executive Officer, effective June 1, 2025. Green will succeed Mike Hays, the company's current CEO, who will transition to the role of Chairman, ensuring a smooth leadership transition while maintaining NRC Health's mission-driven and shareholder-focused approach.
Neutral
Business Wire
3 months ago
UofL Health Chooses NRC Health to Elevate Patient and Employee Experience Initiatives
LOUISVILLE, Ky.--(BUSINESS WIRE)-- #EmployeeExperience--UofL Health selects NRC Health to elevate patient and employee experience across its health system.
Neutral
Business Wire
4 months ago
NRC Health ranked #1 Best in KLAS for Healthcare Experience Management
LINCOLN, Neb.--(BUSINESS WIRE)-- #BIK--NRC Health, a leader in advanced technology and data-driven insights to deliver Human Understanding across the healthcare ecosystem, has proudly announced its recognition as the recipient of the esteemed 2025 Best in KLAS Award for Healthcare Experience Management for the second time in three years. This award once again underscores NRC Health's relentless pursuit of excellence in healthcare experience management through innovation and deep partnerships, in which.
Negative
Zacks Investment Research
4 months ago
National Research's Q4 Earnings Drop Y/Y, Stock Falls 9%
NRC's Q4 EPS drops to 28 cents despite revenue growth, hit by rising costs and higher interest expenses.
Neutral
Business Wire
4 months ago
National Research Corporation Announces Fourth Quarter Results
LINCOLN, Neb.--(BUSINESS WIRE)--National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the fourth quarter 2024 and other corporate developments. Financial Results Revenue for the quarter was approximately $36.9 million compared with approximately $38.0 million in the 2023 quarter. Earnings per diluted share were $0.28 compared with $0.36 for the 2023 quarter. At December 31, 2024, the Company's net indebtedness (total borrowing minus cash and cash equivalents) w.
Neutral
Zacks Investment Research
6 months ago
Zacks Initiates Coverage of NRC Health With Neutral Recommendation
Discover why Zacks has given NRC Health a "Neutral" rating, being the first on Wall Street to initiate coverage on the stock. Dive into the company's AI innovations, strategic partnerships, and financial resilience, along with the challenges of revenue declines, rising debt and stiff competition.
Neutral
Business Wire
6 months ago
Signature Healthcare Elevates Patient Experience and Workforce Engagement Through Strategic Partnership With NRC Health
LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareInnovation--Signature Healthcare has selected NRC Health to enhance its network through human-centered healthcare solutions and data-driven insights.
Charts implemented using Lightweight Charts™